Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects
NCT01421706 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2012-09-18
Summary
Effects of clopidogrel and clarithromycin on the oral disposition of sibutramine in healthy subjects
Conditions
- Healthy
Interventions
- DRUG
-
Sibutramine-clopidogrel
Sibutramine-clopidogrel
- DRUG
-
sibutramine-Clarithromycin
sibutramine-Clarithromycin
Sponsors & Collaborators
-
Inje University
lead OTHER
Principal Investigators
-
JaeGook Shin, MD,PhD · Inje University
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
More Related Trials
-
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657 ·Status: COMPLETED ·Phase: NA
-
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
NCT06198673 ·Status: NOT_YET_RECRUITING
-
Influence of Varenicline on the Antiplatelet Action of Clopidogrel
NCT01308671 ·Status: UNKNOWN ·Phase: NA
-
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
NCT02922465 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects
NCT02222987 ·Status: COMPLETED ·Phase: PHASE1
-
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
NCT00915733 ·Status: COMPLETED ·Phase: PHASE4
-
Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism
NCT01012193 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT00404781 ·Status: COMPLETED ·Phase: PHASE4
-
Relationship Between Dosage of Clopidogrel and Platelet Aggregation in Chinese With Different Genotype
NCT01710436 ·Status: UNKNOWN
-
Pharmacogenetic and Pharmacokinetic Study of Clopidogrel
NCT01968499 ·Status: COMPLETED
-
Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
NCT01129063 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
NCT01509365 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects
NCT01307657 ·Status: COMPLETED ·Phase: NA
-
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
NCT01263093 ·Status: COMPLETED ·Phase: PHASE1
-
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
NCT01779401 ·Status: COMPLETED ·Phase: NA
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD
NCT06714526 ·Status: RECRUITING ·Phase: NA
-
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT02554721 ·Status: COMPLETED ·Phase: PHASE1
-
H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel
NCT00433784 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Function Assessment for Atherothrombotic Patients
NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac Surgery
NCT01146301 ·Status: COMPLETED ·Phase: PHASE4
-
The Influence of CYP2C19 Polymorphism and Clinical Outcomes in Stroke Patients
NCT02711410 ·Status: COMPLETED
-
Cohort Study of Clopidogrel and Proton Pump Inhibitors
NCT01231867 ·Status: COMPLETED
-
Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics Profile
NCT05516784 ·Status: COMPLETED ·Phase: PHASE4